Advanced Pharma Inc. is recalling approximately 7,000 NitroGlycerin injection syringes because the medication was found to be subpotent, meaning it contains less active drug than labeled. Additionally, stability data for certain lots does not support the current expiration dates when stored in the syringe container system. This recall affects multiple doses and sizes of NitroGlycerin in 5% Dextrose, which were distributed nationwide to hospitals and medical facilities.
Subpotent nitroglycerin may not provide the intended therapeutic effect, which is critical during emergency cardiac events where precise dosing is required to manage chest pain or blood pressure. The lack of stability data also means the drug's effectiveness cannot be guaranteed through its listed expiration date.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.